Plant Health Care Share Discussion Threads

[nurdin] 23/4/2009 11:41

These will require a bit of patience but the ultimate rewards could be huge imo.Evo rates their recent harpin deal with Monsanto at 350p a share...and they have other similiar blockbuster products awaiting commercial deals.

''A small cap with billion-dollar marketing muscle
PHC's technology features in Monsanto's second generation GMO seeds. From
2009, Monsanto will put the full force of its multi-billion dollar marketing
budget behind products that generate substantial royalties for PHC. We value
this revenue stream at 350p per share, and PHC has other technologies with
equivalent potential.''

[nurdin] 20/4/2009 11:25

Some pretty decent sized buys here ..wonder whats going on...

[nurdin] 20/4/2009 08:17

cheers steg..nice write up.

Interest building up here I feel.

[stegrego] 18/4/2009 01:58

Shares mag comment:

News food biotechnology giant Monsanto is accelerating
the launch of its Roundup Ready 2 Yield (RR2)
soybean seeds has positive implications for Plant
Health Care (PHC:AIM) and its Harpin seed coating. House
broker Evolution believes the Plant Health Care technology
could produce royalties worth 350p per share compared to a
160p share price and investors should look to pick up stock.
Monsanto raised its 2009/2010 volume target for its product
from five million to six million acres up to seven million
to eight million. Monsanto makes Roundup Ready seeds
which can be used alongside its best selling weed-killer. The
new seeds will incorporate Plant Health Care's Harpin seed
coating which uses naturally-occurring proteins to boost root
development and crop yields. The Harpin seed coating is the
only one of Plant Health Care's products currently being
commercialised. The company also has two further products
under its belt which could be just as big.
Plant Health Care's share price had a roller-coaster ride in
December when the original announcement of the licensing
deal with Monsanto sent the price up from 165p to 235p, only
for it to be knocked back to its starting position two days
later by Bayer's decision to terminate its contract for the
other main product Myconate. Plant Health Care's shares
have yet to recover from the German firm's decision although
the £72 million cap is in ongoing discussions with other
potential partners for Myconate and hopes to get someone on
board within the next year.
Harpin other's leg apart from the Monsanto deal is its use
as a crop-spray additive, for which Plant Health Care is also
seeking licensing partners. All three products are potential
blockbusters and Plant Health Care only needs one to succeed
to take it in to the big league.

[mdrans1] 16/4/2009 13:42

And in today's Shares mag.

[nurdin] 10/4/2009 16:08

Tipped as a buy in IC I see...:o)

[nurdin] 09/4/2009 16:52

Some nice buys here today..reckon they will be tipped over the weekend

[nurdin] 08/4/2009 09:57

Cant argue with that if you chose to value PHC on a PE basis rather than on their prospects of accelerating revenue generation going forward...and I accept that in the current climate that maybe difficult to digest.However my understanding (from the CEO) is that they may infact record a small profit ($3.2m mentioned) this year which could be several times higher next year if everything works out to plan.I think the brokers are being ultra cautious....but wfdik

[wjccghcc] 07/4/2009 19:14

True nurdin but after Bayer's withdrawal, any new Myconate partnership will take 2-3 years for trials before revenues start. Not knocking the company but I've been following them for 4 years and the nice rosy forecasts are forever being revised down (never up!). They're on an (optimistic) PE of 60 for 2010 and that's before any dilution for the working capital funding they mention in the Monsanto order.

In this kind of market, it's hard to see them having sustained outperformance until sentiment improves IMHO.

[nurdin] 07/4/2009 19:00

Here is a taster for you WJC:



Since Bayer's withdrawal from its Myconate partnership, PHC has opened discussions
with several industry majors and hopes to sign a new license for Myconate within a
year or so. Based on the shares' performance in December 2008, confirmation of a
Myconate deal could see them bounce to 235p; the long-term upside would be even
greater. PHC is also looking to license harpin as a crop spray additive, and a deal for
that product could lift the shares yet further.
Even if the potential Myconate and crop spray deals don't materialise, we believe PHC's
shares will still outperform over the coming years as Monsanto ramps up sales of its
second generation products. The fact that Monsanto is accelerating its RR2 launch will
re-instill some of the confidence in PHC that was lost when Bayer pulled out of its
Myconate development. Good news from the other blockbuster products (which could
come as early as 1Q10) would compel us to raise our 350p target significantly. Buy.

[nurdin] 07/4/2009 12:22

seen the latest brokers note WJC?

[wjccghcc] 07/4/2009 12:17

Except they've been promising explosive growth for the last couple of years and it's always been pushed back.

[nurdin] 07/4/2009 09:38

Amazing that people are selling these..explosive growth in earnings forecast for the coming years.

[nurdin] 06/4/2009 18:44

Steg...I might have something for you if youd like to leave me your email address ..

[nurdin] 06/4/2009 16:50

Hi steg...just completing my research on them.

Initial feedback is that Monasto were originally planning to use harpin on soya bean fields covering about 5-6m acres.The new deal now is for supply to cover almost 7-8m acres which is a huge jump.

PHC have to just sit back and collect royalties which I understand is about 4c per acre.On that basis PHC should record profits of almost $3.2m just for the current year.

The potential going forward is enormous with Monasto planning application over 60m acres within 5 year and over 100m acres over 6yrs.

Mouth watering !!

I will keep digging :o)

[stegrego] 03/4/2009 18:51

Nurdin, good to see you here.

I bought back into these today on the back of the late (and i think missed) Monsanto RNS.

Monsanto reported best ever results yesterday with outstanding numbers and growth.

Didnt buy that many as i want to see how they raise finance first before committing more.

If this goes correctly then its surely a bagger from here if the revenues start to flow.....

[nurdin] 03/4/2009 11:29

If harpin is such a success and they have other technologies to coomercialise,the market will be more than happy to support imo

[mdrans1] 03/4/2009 11:23

"In the light of this development, as well as other technology commercialisation opportunities, the Board is reviewing all financing alternatives to meet the Company's investment and working capital needs, so as to ensure future sales growth potential is realised."

No doubt it was sensible of them to trail this review of financing and put it in context so that there is no misinterpretation when they eventually make an announcement.

[nurdin] 03/4/2009 09:09

John Brady, CEO of Plant Health Care commented, "This order underlines
Monsanto's commitment to the rapid commercialisation of harpin. Plant Health
Care's strategy of commercialising its patented technologies with the world's
largest seed and agrichemical companies is now delivering for our shareholders
and, for the first time in our history, our natural technologies will be applied
by growers to millions of acres."

I cant say I disagree...:o)

[nurdin] 03/4/2009 08:32

..and the chart is turning too :o)

[nurdin] 03/4/2009 08:29

Anyone seen this?



Sneaked in after hours last night.Could be transformational...

[topgallant] 04/2/2009 09:10

Thanks AT useful article

[aim_trader] 03/2/2009 11:41

Tuesday, February 03, 2009
Plant Health Care:

Substantial revenue growth on the horizonCare. Plant Health Care undeniably has products with immense potential, but to maximise the potential, it needs a big company - or companies - to adopt its technology.
Full article ►